[1] |
Kantola T,Ilmakunnas M,Koivusalo AM, et al. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland[J]. Scand J Surg, 2011, 100 (1): 8-13.
|
[2] |
Liu C,Wang YM,Fan K. Epidemiological and clinical features of hepatitis B virus related liver failure in China[J]. World J Gastroenterol, 2011, 17 (25): 3054-3059.
|
[3] |
Kim TY,Kim DJ. Acute-on-chronic liver failure[J]. Clin Mol Hepatol, 2013, 19 (4): 349-359.
|
[4] |
Zamora Nava LE,Aguirre Valadez J,Chávez-Tapia NC, et al. Acute-on-chronic liver failure: a review[J]. Ther Clin Risk Manag, 2014 (10): 295-303.
|
[5] |
Aithal GP. Defining "acute on chronic liver failure": an identity crisis![J]. Indian J Gastroenterol, 2010, 29 (5): 177-180.
|
[6] |
Zheng Z,Li X,Li Z, et al. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression[J]. Exp Ther Med, 2013, 6 (4): 929-936.
|
[7] |
Kantola T,Koivusalo AM,Parmanen S, et al. Survival predictors in patients treated with a molecular adsorbent recirculating system[J]. World J Gastroenterol, 2009, 15 (24): 3015-3024.
|
[8] |
Siciliano M,Parlati L,Maldarelli F, et al. Liver trans-plantation in adults: Choosing the appropriate timing[J]. World J Gastrointest Pharmacol Ther, 2012, 3 (4): 49-61.
|
[9] |
Hessel FP,Bramlage P,Wasem J, et al. Cost-effecti-veness of the artificial liver support system MARS in patients with acute-on-chronic liver failure[J]. Eur J Gastroenterol Hepatol, 2010, 22 (2): 213-220.
|
[10] |
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华肝脏病杂志, 2013, 21(3): 177-183.
|
[11] |
Kamath PS,Wiesner RH,Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33 (2): 464-470.
|
[12] |
Zhao P,Wang C,Liu W, et al. Causes and outcomes of acute liver failure in China [J/OL]. PLoS One, 2013, 8 (11): e80991.
|
[13] |
Nevens F,Laleman W. Artificial liver support devices as treatment option for liver failure[J]. Best Pract Res Clin Gastroenterol, 2012, 26 (1): 17-26.
|
[14] |
Schilsky ML. Acute liver failure and liver assist devices[J]. Transplant Proc, 2011, 43 (3): 879-883.
|
[15] |
Sekido H,Matsuo K,Takeda K, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure[J]. Transplant Proc, 2004, 36 (8): 2355-2356.
|
[16] |
Nyberg SL. Bridging the gap: advances in artificial liver support[J]. Liver Transpl, 2012, 18 Suppl 2: S10-S14.
|
[17] |
Xu X,Liu X,Ling Q, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J/OL]. PLoS One, 2013, 8 (3): e58738.
|
[18] |
Malinchoc M,Kamath PS,Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31 (4): 864-871.
|
[19] |
Freeman RB,Wiesner RH,Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy[J]. Liver Transpl, 2002, 8 (9): 851-858.
|
[20] |
Yu JW,Sun LJ,Zhao YH, et al. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment[J]. J Gastroenterol Hepatol, 2008, 23 (8 Pt 1): 1242-1249.
|
[21] |
Sun QF,Ding JG,Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model[J]. J Viral Hepat, 2009, 16 (7): 464-470.
|
[22] |
Zheng MH,Shi KQ,Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9 (4): 351-356.
|
[23] |
Sun LJ,Yu JW,Zhao YH, et al. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure[J]. J Gastroenterol Hepatol, 2010, 25 (3): 583-590.
|
[24] |
Wong VW,Wong GL,Yiu KK, et al. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B[J]. J Hepatol, 2011, 54 (2): 236-242.
|
[25] |
杨波,吴元凯,陈忠诚, 等. ALT、AST、TBil及PT变化趋势与慢加急性乙型肝炎肝衰竭预后的关系[J]. 临床肝胆病杂志, 2012, 28(3): 205-208.
|
[26] |
Zheng YB,Huang ZL,Wu ZB, et al. Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study[J]. Int J Med Sci, 2013, 10 (12): 1658-1664.
|
[27] |
Xun YH,Shi JP,Li CQ, et al. Prognostic performance of a series of model for end-stage liver disease and respective delta scores in patients with hepatitis B acute-on-chronic liver failure[J]. Mol Med Rep, 2014, 9 (5): 1559-1568.
|